SELLAS Life Sciences Reports Second Quarter 2021 Financial
Reported Promising Updated Clinical Data in Ongoing Clinical Trials of Galinpepimut-S (GPS) in Combination with PD-1 Inhibitors for Malignant Pleural...
Source: globenewswire.com
Page 26 - Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sciences Group Today - Breaking & Trending Today
FastForward Innovations Ltd investee Yooma Wellness Inc plans dual listing in London
In addition to its planned listing on the Aquis Stock Exchange, Yooma is also planning to raise up to £10mln to fund three acquisitions in the cannabis...
Source: proactiveinvestors.co.uk
Sellas Life Sciences Stock May Have Broken Out Of Pennant Pattern: What's Next?
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) shares rallied...
Source: benzinga.com
What's on Sunday news shows in Rhode Island, May 30, 2021
Sunday news shows in RI, May 23, 2021
Source: providencejournal.com
MM+M 40 Under 40: The Next Wave - 40 Under 40 - MM+M - Medical Marketing and Media
MM+M presents the 40 Under 40 list, highlighting marketers shining a spotlight on the industryâs breadth of young talent, many of whom are poised to lead the business in the decades ahead. Scott Aldrich Jr., VP, global marketing and strategy, Motus GI Scott Aldrich Jr.âs experience with medical device companies that operate with marketing as a hub means that he acts as a cross-functional leader, aligning marketing, operations, sales and strategy teams in product-driven collaboration. In his current role, Aldrich oversees marketing at medtech company Motus GI, whose goal is to improv...
Source: mmm-online.com